AMPHIX BIO, INC.
Peptide amphiphile supramolecular polymers for spinal fusion surgery
- Sector
- Medtech
- Headquarters
- CHICAGO, IL
- Latest Form D
- $10.3M, Dec 2025
- Total capital
- $11.6M
- Federal grants
- $1.3M
- 2 awards · 2022–2024
- Rank in peer group#13 of 27
- Private capital raised
- $10.3M
- 1 Form D · last Dec 2025
- 10 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 3 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$10.3M
- Federal grantNSF · Phase II · SBIR Phase II: Scalable Manufacturing of Supramolecular Polymers for Regenerative Medicine$1M
- Federal grantNSF · Phase I · SBIR Phase I:Scalable Manufacturing of Supramolecular Polymers for Regenerative Medicine$253K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
46months
from AMPHIX BIO, INC.’s first federal award to its first private round.
- First federal award · Mar 2022
- NSF · $253K
- First Form D · Dec 2025
- $10.3M · 1st Form D
- Awards before first raise
- 2 awards
An association in public records, not a cause or a prediction.
Standing among 27 peers
Line = medianMedtech · Material
- Federal grants#13 · top 48%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- John PotocsnakDirectorNamed in SEC Form D filings
- Kok-Wai WongDirectorNamed in SEC Form D filings
- Nicholas SatherExecutive Officer, DirectorNamed in SEC Form D filings
- Samuel StuppExecutive Officer, DirectorNamed in SEC Form D filings
- Stephen R WilsonDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 3- PendingSupramolecular Polymer Putty For Bone/tissue RegenerationUSPTOApplication 19103600
- PendingSupramolecular Polymer Putty For Bone/tissue RegenerationUSPTOApplication PCTUS2023072387
- PendingSupramolecular Polymer Putty For Bone/tissue RegenerationUSPTOApplication 63399467
Related companies, and why
- ANIMATED DYNAMICS, INCSimilar federal contract value in Medtech · null in contracts
- TERRY VENTURES, LLCSimilar federal contract value in Medtech · null in contracts
- HillromSimilar federal contract value in Medtech · null in contracts
- I-FUNCTION, INC.Similar federal contract value in Medtech · null in contracts
- Ion Dx, Inc.Similar federal contract value in Medtech · null in contracts
- Medicool TechnologiesSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .